PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2016

Intraluminal tranexamic acid inhibits intestinal sheddases and mitigates gut and lung injury and inflammation in a rodent model of hemorrhagic shock.

Mouse / Haemorrhage/shock

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 27027557 ↗2016Reported benefit

Intraluminal tranexamic acid inhibits intestinal sheddases and mitigates gut and lung injury and inflammation in a rodent model of hemorrhagic shock.

MouseHaemorrhage/shockControlledC57BL/6JMaleIntraluminal administration into the small bowelImmediately after the 90 minute haemorrhagic shock period

Model: Haemorrhagic shock, bled to a mean arterial pressure of 35 plus or minus 5 mmHg and maintained for 90 minutes

Intraluminal tranexamic acid significantly reduced gut and lung histopathological injury and inflammation compared with haemorrhagic shock alone. ADAM-17 and TNF alpha in gut, lung and the systemic circulation were significantly increased by haemorrhagic shock and lessened by tranexamic acid, and g…

Extraction: extract · Subtype source: llm · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.